azomycin has been researched along with atorvastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiub, CAF; Araujo-Lima, CF; Batista, MM; Felzenszwalb, I; Peres, RB; Silva, PB; Soeiro, MNC | 1 |
| Campos-Estrada, C; Denegri, M; González-Herrera, F; Kemmerling, U; Maya, JD; Urarte, E; Villalón, L | 1 |
1 trial(s) available for azomycin and atorvastatin
| Article | Year |
|---|---|
Effect of statins on inflammation and cardiac function in patients with chronic Chagas disease: A protocol for pathophysiological studies in a multicenter, placebo-controlled, proof-of-concept phase II trial.
Topics: Atorvastatin; Chagas Disease; Clinical Trials, Phase II as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Multicenter Studies as Topic; Nitroimidazoles; Persistent Infection; Randomized Controlled Trials as Topic; Trypanocidal Agents; Trypanosoma cruzi | 2023 |
1 other study(ies) available for azomycin and atorvastatin
| Article | Year |
|---|---|
Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
Topics: Animals; Atorvastatin; Cell Line; Chagas Disease; Drug Repositioning; Drug Synergism; Drug Therapy, Combination; Heart; Mice; Nitroimidazoles; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2018 |